The present protocol describes methods for evaluating DNA damage repair proteins in patient-derived ovarian cancer organoids. Included here are comprehensive plating and staining methods, as well as detailed, objective quantification procedures.

Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids via Immunofluorescence Assays

•

•

•

Chapters

Summary

Automatic Translation

Tags

Article

Embed

ADD TO PLAYLIST

Usage Statistics

Related Videos

Evaluating In Vitro DNA Damage Using Comet Assay

Characterizing DNA Repair Processes at Transient and Long-lasting Double-strand DNA Breaks by Immunofluorescence Microscopy

Establishment of Gastric Cancer Patient-derived Xenograft Models and Primary Cell Lines

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Immunofluorescence Imaging of DNA Damage and Repair Foci in Human Colon Cancer Cells

High-Throughput In Vitro Assay using Patient-Derived Tumor Organoids

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Generation and Culturing of High-Grade Serous Ovarian Cancer Patient-Derived Organoids

Establishment and Culture of Patient-Derived Breast Organoids

Quantifying Replication Stress in Ovarian Cancer Cells Using Single-Stranded DNA Immunofluorescence

Read Article